LETTERS TO THE EDITOR

Increased CD4 + and CD8 + effector memory T cells in patients with aplastic anemia
In the present study, we initially reported that the percentages of CD4 + and CD8 + effector memory T cells (TEM cells) were increased in PB and BM of AA. The elevated TEM cells with the potent effector capacity may relate to the abnormal immune status in the pathogenesis of AA.
T-cell mediated suppression of hematopoiesis is considered the pivotal mechanism responsible for bone marrow failure in aplastic anemia (AA). 1 In patients with AA, oligoclonal T cells in marrow were detected to show mature memory/effector phenotypes, 2 implicating memory T cells might participate in the pathophysiological process of AA. Based on the ability to express chemokine receptor CCR7 and the phosphatase CD45RA, CD4 + 
CCR7
-TEM cells (terminal TEM cells). 3, 4 Perturbation in the homeostasis of memory T cells has been reported in several T-cell mediated autoimmune diseases. [5] [6] [7] In the present study, we initially investigated the distribution and function of naïve T cells, TCM cells, and TEM cells in patients with AA.
The study was approved by the Ethics Committee of Qilu Hospital, Shandong University, and informed consent was obtained from each participant. Forty-five newly-diagnosed untreated patients with AA (23 males and 22 females, mean age 36 years, range 18-69) were enrolled in this study. Criteria for the diagnosis and severity classification of AA were as previously reported.
8,9
Out of 45 patients, 27 patients were diagnosed with severe AA (SAA) and 18 patients with moderate AA (MAA). No patient with AA had received any treatment or transfusion before enrollment. Thirty gender-and agematched healthy volunteers served as controls (16 males, 14 females, mean age 41 years, range 21-67).
Freshly isolated peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMNCs) were stained with FITC-conjugated anti-CD45RA, PE-conjugated anti-CCR7, and PE-Cy5-conjugated anti-CD4 or PE-Cy5-conjugated anti-CD8 (BD Biosciences, San Diego, CA, USA) to measure percentages of naïve T cells, TCM cells and TEM cells in CD4 + and CD8 + T cells in both PBMCs and BMMNCs. For the important pathogenic role of T cell-produced IFN-γ in AA, intracellular cytokine IFN-γ production by different T-cell subsets was detected to assess their function. PBMCs and BMMNCs were simulated with 25 ng/mL PMA and 1 umol/L ionomycin in the presence of 2 ug/mL monesin (Sigma, St Louis, MO, USA) for 5h. After staining with PE-conjugated anti-CCR7 and PE-Cy5-conjugated anti-CD4 or PE-Cy5-conjugated anti-CD8, cells were fixed and permabilized and then stained with FITC-conjugated anti-IFN-γ (BD Biosciences). Stained cells were analyzed on a FACSCalibur flow cytometer using a buildin CellQuest software (BD Biosciences, San Diego, CA, USA). Statistical analyses were performed using SPSS 11.5 for Windows (SPSS Inc., Chicago, IL, USA). Differences between two groups were analyzed by Student's t test. In the CD4 + T-cell population, significantly decreased percentages of CD45RA + CCR7
+ naïve T cells were observed in PBMCs and BMMNCs of AA patients compared with controls ( Figure 1A and B) . In contrast, the percentages of CD45RA -CCR7-TEM cells in PBMCs and BMMNCs were higher in AA patients than in controls ( Figure 1B) . As far as CD8 + T-cell population was concerned, patients with AA still had decreased percentages of CD45RA + CCR7
+ naïve T cells in PBMCs and BMMNCs compared with controls ( Figure 1A and C) -terminal TEM cells were increased in PBMCs and BMMNCs of patients with AA compared with controls ( Figure 1C ). There was no significant difference between patients with AA and controls in the percentages of CD4 + and CD8 + CD45RA -CCR7 + TCM cells from PBMCs or BMMNCs ( Figure 1C) . In CD4 + and CD8 + T-cell population of PBMCs and BMMNCs, no significant difference in percentages of naïve and memory T-cell subsets was detected between SAA and MAA, suggesting that the distribution of CD4 + and CD8 + T-cell subsets Percentages of T-cell subsets in PBMCs were also compared with those in BMMNCs. There were no significant differences in T-cell subsets in CD4 + T cells between PBMCs and BMMNCs in either patients with AA or controls ( Figure 1B) . Concerning the CD8 + T-cell population, significantly increased CD45RA + CCR7
-terminal TEM cells and decreased CD45RA + CCR7 + naïve T cells were observed in BMMNCs compared with PBMCs in AA patients, but no difference was detected in controls ( Figure 1C) .
Chemokine receptor CCR7 is essential for lymphocyte migration to secondary lymphoid organs. Compared with naïve T cells and TCM cells, TEM cells lack CCR7 expression and fail to migrate to lymph nodes, but TEM cells have acquired potential to rapidly enter inflamed tissues, secrete large amounts of cytokines and display immediate effector function.
3,4 Our finding of higher percentages of CD4 + and CD8 + TEM cells in peripheral blood (PB) and bone marrow (BM) of patients with AA suggests TEM cells expand in AA and are recruited to BM.
In humans, the TEM pool contains Th1, Th2 and CTL.
3,10
In the present study, CD4 + and CD8 + CCR7 -TEM cells from both PBMCs and BMMNCs, compared with CCR7 
CCD7
-TEM cells from both PBMCs and BMMNCs was significantly higher in patients with AA than normal controls ( Figure 2B) 
